John Austin Hanna | RS Hanna Gallery | Fredericksburg, Texas
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research...
-
Upload
howard-scott -
Category
Documents
-
view
214 -
download
0
Transcript of Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research...
Cohort StudiesCohort Studies
Hanna E. Bloomfield, MD, MPHHanna E. Bloomfield, MD, MPHProfessor of MedicineProfessor of Medicine
Associate Chief of Staff, ResearchAssociate Chief of Staff, Research
Minneapolis VA Medical CenterMinneapolis VA Medical Center
Empowering Evidence 2014
DisclosureDisclosure
• I have no financial relationships to disclose.
• I will not discuss off label use and/or investigational use in my presentation
Empowering Evidence 2014
Learning Objectives
By the end of this session participants should understand
•The difference between a prospective and retrospective cohort study•The difference between a cohort and a case control study •The concept of bias•The concept of confounding
Empowering Evidence 2014
Evidence Pyramid
Clinical, Epidemiologic,Health Services
Increasing strength of evidence for
clinical application
Basic Science
Empowering Evidence 2014
Cohort Studies
• Overview
• How they differ from Case Control Studies
• Bias
• Confounding
• Characteristics of a GOOD cohort study
Empowering Evidence 2014
Cohort Studies
May be used to study…
• Etiology/ Risk Factors/Prognosis
• Effect of Treatments– Hypothesis generating!
• May be either– Prospective– Retrospective
Empowering Evidence 2014
Prospective Cohort Study To evaluate Etiology/Risk Factors/Prognosis
samplesample
1000High blood pressure
1000High blood pressure
60 Heart Attacks
60 Heart Attacks
Risk Factor Follow-up Outcome
populationpopulation
1000Normal blood pressure
1000Normal blood pressure 20 Heart
Attacks20 Heart Attacks
Study begins here
PRESENT, 2014 FUTURE, 2014-18
Empowering Evidence 2014
Retrospective Cohort Study To evaluate Etiology/Risk Factors/Prognosis
samplesample
1000High blood pressure
1000High blood pressure
60 Heart Attacks
60 Heart Attacks
Risk Factor Follow-up Outcome
populationpopulation
1000Normal blood pressure
1000Normal blood pressure 20 Heart
Attacks20 Heart Attacks
You act as if study begins here
PAST, 2008 PRESENT, 2014
Empowering Evidence 2014
Cohort Study Cohort Study To evaluate Treatment To evaluate Treatment
Hypothesis generating onlyHypothesis generating only
samplesample
1000on treatment
1000on treatment
60 Heart Attacks
60 Heart Attacks
Risk Factor Follow-up Outcome
Population of middle agepeople with high blood pressure
Population of middle agepeople with high blood pressure
1000not on treatment
1000not on treatment 20 Heart
Attacks20 Heart Attacks
Study begins here
PRESENT, 2014 FUTURE, 2014-18
Empowering Evidence 2014
Cohort Studies• Overview
• How they differ from Case Control Studies
• Bias
• Confounding
• Characteristics of a GOOD cohort study
Empowering Evidence 2014
Case Control StudiesCase Control StudiesTo evaluate Etiology/Risk FactorsTo evaluate Etiology/Risk Factors
PAST PRESENT, 2014
1000Prior Heart
Attack
1000Prior Heart
Attack
1000No Prior Heart
Attack
1000No Prior Heart
Attack
60%High blood pressure
60%High blood pressure
20%High blood pressure
20%High blood pressure
Study begins here
Empowering Evidence 2014
1000
Prior heart attack
1000
Prior heart attack
1000
No prior heart attack
1000
No prior heart attack
20%On Aspirin
20%On Aspirin
60%On Aspirin
60%On Aspirin
PAST PRESENT, 2014
Study begins here
Case Control StudiesCase Control StudiesTo evaluate Treatment EfficacyTo evaluate Treatment Efficacy
Empowering Evidence 2014
Cohort v. Case ControlCohort v. Case Control• Cohort (either prospective or retrospective)
– Subjects are defined by risk factor/treatment status
– Disease occurrence in the future is then assessed and compared
• Case Control – Subjects are defined by disease status– Past history of risk factor/treatment are then
assessed and compared
Empowering Evidence 2014
Cohort StudiesCohort Studies• Overview
• How they differ from Case Control Studies
• Bias
• Confounding
• Characteristics of a GOOD cohort study
Empowering Evidence 2014
Bias and ConfoundingBias and Confounding
• Two problems that can undermine validity of cohort studies
• Bias– Systematic error in the design, conduct, or
analysis of a study
• Confounding– It looks like Factor A causes Disease X but in
fact it is Factor B
Empowering Evidence 2014
BiasBias
• There are a million types of bias!!
• Some common ones to look for…– Selection bias– Information bias
Empowering Evidence 2014
Selection Bias: exampleSelection Bias: exampleTo evaluate Etiology/Risk FactorsTo evaluate Etiology/Risk Factors
samplesample
1000High blood pressure
1000High blood pressure
60 Heart Attacks
60 Heart Attacks
populationpopulation
1000Normal blood pressure
1000Normal blood pressure 20 Heart
Attacks20 Heart Attacks
• HBP recruited from a cardiology clinic• Normal BP from a primary care clinic• What’s wrong with this picture??
Empowering Evidence 2014
Selection BiasSelection Bias
• Systematic difference in prognostic or treatment factors between the 2 groups
• In our example….– One group is more likely to have more cardiac
risk factors or history than the other– One group is more likely to be aggressively
treated than the other (eg lipids)
Empowering Evidence 2014
Information BiasInformation BiasTo evaluate Etiology/Risk FactorsTo evaluate Etiology/Risk Factors
• Heart Attack incidence is measured from hospital records in one group and from patient recall in another
• What’s wrong with this picture??
samplesample
1000High blood pressure
1000High blood pressure
60 Heart Attacks
60 Heart Attacks
populationpopulation
1000Normal blood pressure
1000Normal blood pressure 20 Heart
Attacks20 Heart Attacks
Empowering Evidence 2014
BiasBias
• Systematic error in the design, conduct, or analysis of a study
• The question to ask yourself when reading a study: Did they do things differently between the 2 groups?– Recruitment? Treatment? Follow-up?
Ascertainment of Endpoints? Analysis of Data?
Empowering Evidence 2014
ConfoundingConfounding
• This is the main problem in ALL observational studies
• Bias is under control of investigators– Did they do things differently between the
2 groups?
• Confounding is NOT under the control of the investigators– It is endemic to observational studies– But it can be mitigated
Empowering Evidence 2014
We do this cohort study…We do this cohort study…To evaluate Etiology/Risk FactorsTo evaluate Etiology/Risk Factors
• We have done a good job controlling for bias• We find a significant association between a
history of HBP and risk of heart attack• Is that the end of the story?
samplesample
1000High blood pressure
1000High blood pressure
60 Heart Attacks
60 Heart Attacks
populationpopulation
1000Normal blood pressure
1000Normal blood pressure 20 Heart
Attacks20 Heart Attacks
P<0.001
Empowering Evidence 2014
We still don’t know if…We still don’t know if…
• Its the high BP that increases the risk of heart attack or something else (that frequently
accompanies HBP) that is actually the culprit
• In other words, is there “confounding”?
Empowering Evidence 2014
Before we can definitively say that high blood pressure is a risk factor for heart
attacks, we need to rule out confounding
Before we can definitively say that high blood pressure is a risk factor for heart
attacks, we need to rule out confounding
High Blood PressureHigh Blood Pressure
Heart AttacksHeart Attacks
Risk factor Risk factor
OutcomeOutcome
ConfoundingConfoundingin Risk Factor/Etiology Studiesin Risk Factor/Etiology Studies
Empowering Evidence 2014
Population: Middle Aged People in the US
No HBP HBP
20 heartattacks
60 heart attacks
sample
Empowering Evidence 2014
Population: Middle Aged People in the US
No HBP HBP
20 heartattacks
60 heart attacks
sample
SmokeDon’t Exercise
Have highcholesterol
Don’t SmokeExercise
Have normal cholesterol
Empowering Evidence 2014
Confoundingin Risk Factor/Etiology Studies
High Blood PressureHigh Blood Pressure
Heart AttacksHeart Attacks
Risk factor Risk factor
OutcomeOutcome
HighCholesterol
HighCholesterol
Confounding VariableConfounding VariableA variable that is associated with both
the risk factor and the diseaseA variable that is associated with both
the risk factor and the disease
Empowering Evidence 2014
Confoundingin Treatment Studies
Treatment of High Blood Pressure
Treatment of High Blood Pressure
Heart AttacksHeart Attacks
Empowering Evidence 2014
Population: Middle Aged People in the with HBP
HBP treated
HBP Not treated
20 heartattacks
60 heart attacks
sample
Empowering Evidence 2014
Population: Middle Aged People in the with HBP
HBP treated
HBP Not treated
20 heartattacks
60 heart attacks
sample
Don’t getother
interventions
Get other Interventions
e.g. aspirin
Empowering Evidence 2014
Confounding
• A problem in even the most meticulously conducted cohort study
• There are ways to mitigate its effects– Have all the likely confounders been
identified?– Have the authors used appropriate statistical
techniques for dealing with potential confounders?
Empowering Evidence 2014
Confounding
• But it can never be totally ruled out in an observational study (cohort, case-control)
• You can deal with the known confounders– “control for”, “adjust for” them
• But you can’t deal with the unknown, unmeasured ones
Empowering Evidence 2014
Confounding
• The only way to avoid confounding is to do a randomized trial– Randomization balances the known and
unknown risk factors evenly between the two groups
• Treatment decisions (especially for prevention) should be based on randomized trial data
Empowering Evidence 2014
Cohort Studies
• Overview
• How they differ from Case Control Studies
• Bias
• Confounding
• Characteristics of a GOOD cohort study
Empowering Evidence 2014
Features of Good Cohort StudiesFeatures of Good Cohort Studies• Sample representative and assembled at a
common point in time• Follow-up sufficiently long and complete• Outcome criteria objective or applied in a blinded
fashion• Adjustment for possible confounding (prognostic
factors)• Results reported with time to event curves (if f/u
longer than a few months)• Precision of the effect size reported (CI)
Empowering Evidence 2014
Small Group ExerciseSmall Group Exercise
Glucose Levels and Risk of DementiaCrane et al NEJM 2013; 369(6):540-548
Start by reading the abstract …Then try to answer these questions
• What kind of study was this?• Was follow-up sufficiently long and complete?• Were the outcome criteria objective or applied in a blind fashion?• Was adjustment for prognostic factors (confounding) done?• Were outcomes reported over time (ie time to event analysis)?• How precise were the estimates of prognosis?• How would you apply the results of this study in your practice?